This COVID-19 roundup details the development of vaccine passports, the decrease in vaccine hesitancy, the results of a study into the effectiveness of the Pfizer-BioNTech COVID-19 vaccine, and the United...
This COVID-19 roundup details the results of a study into the effectiveness of a new AstraZeneca vaccine, the spread of the UK variant in the United States, and how vitamin D levels affect outcomes.
New data from a recently published case report detail the first infant with antibodies to SARS-CoV-2 born to a mother vaccinated against the virus during pregnancy.
On February 27, 2021, the US Food and Drug Administration issued an emergency use authorization (EUA) for the Janssen COVID-19 vaccine. This is the third vaccine authorized by the FDA to prevent COVID-19.
...
This COVID-19 roundup details results of a study examining the relationship between preexisting conditions and risk of hospitalization with COVID-19, an FDA statement regarding the J&J vaccine, and...
A physician-reported registry of adults with rheumatic diseases and with confirmed or presumed cases of COVID-19 indicates that some therapies, as well severity of disease, are associated with higher death...
The World Health Organization (WHO) has issued interim recommendations for the use of the AZD1222 (ChAdOx1-S [recombinant]) AstraZeneca-Oxford adenovirus-vectored COVID-19 vaccine.
The US Food and Drug Administration has issued an emergency use authorization for a new combination of monoclonal antibodies for treating patients with mild to moderate COVID-19 who are at risk of...
The number of US adults who report they will get the COVID-19 vaccine is on the rise, but is this enough to match the population percentage needed to reach herd immunity?
